The (mammalian target of rapamycin (mTOR) pathway is known to be activated in multiple myeloma and may play an important role in this process by potentially up-regulating the scavenger receptor (SR-BI), although detailed mechanism information is still elusive [44,45,46,47]. This evidence concerns the gene MTOR and plasma cell myeloma.